The effect of seed orientation deviations on the quality of 125I prostate implants.

We quantified the effect of seed orientation deviations on five prostate seed implant cases at our institution. While keeping their positions fixed, the iodine-125 seeds were assigned orientations sampled from a realistic probability distribution derived from the post-implant radiographs of ten patients. Dose distributions were calculated with both a model that explicitly includes anisotropy (TG43 anisotropy function) and a point source model (TG43 anisotropy factor). Orientation deviations had only a small influence on prostate dose-volume histograms: the 95% confidence intervals on the volumes receiving 100%, 150% and 200% dose were at most +/-0.8%, +/-1.1% and +/-0.6% of the prostate volume, respectively. The dose-volume histograms of anisotropic seed distributions were marginally better than those with isotropic point-source seeds. Anisotropy caused a displacement of cold spots (regions receiving <100% of the prescribed dose) in <1% of the prostate volume. Our results indicate no net benefit to prostate dosimetry in using more isotropic seeds. Furthermore, we propose a new 'weighted anisotropy function' to better account for the effects of anisotropy when seed orientation is unknown. Conceptually, the TG43 anisotropy factor described in AAPM TG43 averages the effect of anisotropy over all solid angles, with the implicit assumption that all seed orientations are equally probable. In prostate implants, however, seeds are preferentially oriented parallel to the needle axis. The proposed weighted anisotropy function incorporates this non-uniform probability.

[1]  S. C. Prasad,et al.  Dose distribution for 125I implants due to anisotropic radiation emission and unknown seed orientation. , 1987, Medical physics.

[2]  J. Battista,et al.  The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd. , 2001, Medical physics.

[3]  M Wannenmacher,et al.  Seed loss in interstitial radiotherapy of prostatic carcinoma with I-125. , 1988, International journal of radiation oncology, biology, physics.

[4]  W. Butler,et al.  Seed fixity in the prostate/periprostatic region following brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[5]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[6]  W. Butler,et al.  Isotope choice and the effect of edema on prostate brachytherapy dosimetry. , 2000, Medical physics.

[7]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[8]  L. Anderson,et al.  Functional fitting of interstitial brachytherapy dosimetry data recommended by the AAPM Radiation Therapy Committee Task Group 43. American Association of Physicists in Medicine. , 1999, Medical physics.

[9]  S Nag,et al.  The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. , 2000, International journal of radiation oncology, biology, physics.

[10]  N. Yue,et al.  Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution. , 2000, International journal of radiation oncology, biology, physics.

[11]  J Pouliot,et al.  Monte Carlo simulations of prostate implants to improve dosimetry and compare planning methods. , 1999, Medical physics.

[12]  R Nath,et al.  Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. , 1999, Medical physics.

[13]  H H Holm,et al.  Ultrasound-guided implantation techniques in treatment of prostate cancer. , 1989, The Urologic clinics of North America.

[14]  B W Corn,et al.  Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study. , 1997, International journal of radiation oncology, biology, physics.

[15]  W. Butler,et al.  Comparison of seed loading approaches in prostate brachytherapy. , 2000, Medical physics.

[16]  Julie Dawson,et al.  Dose effects of seeds placement deviations from pre-planned positions in ultrasound guided prostate implants , 1994 .

[17]  Zhe Chen,et al.  Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds. , 2000, Medical physics.

[18]  H. Holm,et al.  Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. , 1983, The Journal of urology.

[19]  N. Yue,et al.  Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition. , 1998, International Journal of Radiation Oncology, Biology, Physics.